Bauxite mining at Atewa Forest Reserve, Ghana: a political ecology of a conservation-exploitation conflict.

Atewa Forest Reserve in the Eastern Region of Ghana represents one of only two reserves with upland evergreen forests in Ghana but is also a possible site for bauxite mining. The Government of Ghana deployed an infrastructure in anticipation for a refined bauxite agreement with China. Ghana's Government seeks to develop an integrated Bauxite-Aluminum Industry; however, several NGOs try to protect the Atewa Forest and propose that the area should be upgraded to a National Park.

Cost-of-illness of psoriasis - results of a German cross-sectional study.

Background: Though psoriasis poses a substantial chronic socio-economic burden, few studies have addressed the economic impact in Germany.

Objectives: The objective was to evaluate the annual costs of psoriasis in Germany from the societal perspective.

Methods: A cross-sectional study was performed in randomly selected German dermatology practices and clinics in 2013/2014 using standardized questionnaires of illness-related costs.

Cost-of-illness of patients with lymphoedema.

Background: Chronic lymphoedema is characterized by a continuous need for medical treatment, many comorbidities and impaired quality of life. In Germany, about 4.5 million patients are affected by lymphoedema.

Quality of psoriasis care in Germany: results of the national health care study "PsoHealth3".

Two national surveys conducted in 2005 and 2007 indicated deficits in psoriasis care and induced the composition of the ''National Goals for Health Care in Psoriasis 2010-2015''. The aim of this work was to (1) evaluate the quality of care for patients with psoriasis in Germany, (2) compare this with prior psoriasis studies PsoHealth1 (2005) and PsoHealth2 (2007), and (3) review the implementation of national treatment goals. By means of a cross sectional study the following indicators of health care quality were collected: psoriasis severity (Psoriasis Area Severity Index (PASI) and proportion of PASI >20), quality of life (Dermatology Life Quality Index (DLQI) were corporated: proportion of DLQI >10), previous systemic treatment, inpatient treatment, and days absent from work due to psoriasis.

Prevalence of Obesity in Patients with Psoriasis: Results of the National Study PsoHealth3.

Background: Psoriasis is frequently associated with obesity which possibly contributes to reduced treatment response.

Objectives: Assessment of the prevalence of obesity in patients with psoriasis in Germany 2013/2014.

Patients And Methods: The frequency of overweight and obesity was assessed by the body mass index (BMI) and evaluated according to the severity of psoriasis [Psoriasis Area and Severity Index (PASI)].